A Study of AC682 In Chinese Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT05489679 · TERMINATED
Trial details
- NCT number
- NCT05489679
- Sponsor
- Accutar Biotechnology Inc
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-09-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.